Bertrand Gachot - Concepedia

Author

Bertrand Gachot

Also Known As

B Chevalier, B Gachot, B. Fumery, B. Gachot, Bertrand Gachot, Elisabeth Chachaty, Eric Deutsch, Gachot, Brendan, M. Assicot, Patil, S.B.

150

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Institut Gustave Roussy Hôpital Bichat-Claude-Bernard Université Claude Bernard Lyon 1 Assistance Publique – Hôpitaux de Paris Université Paris Cité

About

Bertrand Gachot is an author at Institut Gustave Roussy specializing in medicine, infection control, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	29	2.8K
2	Health Sciences	3	3	267
3	Cell Biology	3	3	85
4	Cellular Physiology	2	2	42
5	Public Health	1	1	29

Bertrand Gachot

Publications

Citations

H-Index

Page 1

	Year	Citations
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, Cell Mild Covid-19Hematological MalignancyHematologyImmunologyPathology	2020	898
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update Johan Maertens, Oscar Marchetti, Raoul Herbrecht, Bone Marrow Transplantation Hematological MalignancyTranslational MedicineAntifungal AgentTransplantationAntifungal Management	2010	465
Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments Bertrand Souweine, Benoît Veber, Jean Pierre Bedos, Critical Care Medicine	1998	220
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams Emmanuel Weiss, J.-R. Zahar, P. Lesprit, Clinical Microbiology and Infection PharmacologyConsensual DefinitionMolecular Biology	2015	190
Treatment with Piperacillin‐Tazobactam and False‐Positive<i>Aspergillus</i>Galactomannan Antigen Test Results for Patients with Hematological Malignancies Olivier Adam, Anne Aupérin, Fanny Wilquin, Clinical Infectious Diseases Diagnostic MycologyHematology PatientsImmunologyPathologyHematological Malignancies	2004	184
Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures François Blot, Marguerite Guiguet, G. Nitenberg, European Journal of Cancer Critical Care ManagementPrognostic FactorsPrognostic EvaluationIntensive Care UnitMedicine	1997	148
Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031) Oliver A. Cornely, Bertrand Gachot, Hamdi Akan, Clinical Infectious Diseases	2015	138
Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia Jean‐François Timsit, C. Cheval, Bertrand Gachot, Intensive Care Medicine Interventional PulmonologyAntibioticsSuspected Ventilator-associated PneumoniaRespiratory InfectionBronchoalveolar Lavage Fluid	2001	125
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort Laurence Albigès, Stéphanie Foulon, Arnaud Bayle, Nature Cancer	2020	117
A retrospective series of gut aspergillosis in haematology patients Eyad Kazan, J Maertens, Raoul Herbrecht, Clinical Microbiology and Infection Gut AspergillosisPathologyFungal Pathogen	2010	103

Page 1